Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Gynecologic 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 31Colorectal Neoplasms 12Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Neoplasms 7Liver Neoplasms 7Esophageal Neoplasms 6Carcinoma, Renal Cell 6Neoplasm Metastasis 5Gastrointestinal Neoplasms 5Adenoma, Islet Cell 5Neuroendocrine Tumors 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Prostatic Neoplasms 3Carcinoma 3Thyroid Neoplasms 2Sarcoma 2Rectal Neoplasms 2Neoplasms, Glandular and Epithelial 2Neoplasms by Site 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lung Neoplasms 2Hematologic Neoplasms 2Digestive System Neoplasms 2Colonic Neoplasms 2Adenoma 2Adenocarcinoma Of Esophagus 2

Interventions

belinostat 2sargramostim 1rucaparib 1rubitecan 1romidepsin 1pembrolizumab 1brostallicin 1Trabectedin 1Therapeutics 1Sunitinib 1Radiation, Ionizing 1Nivolumab 1Imatinib Mesylate 1HhAntag691 1Fluorouracil 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyosarcoma × Sunitinib × Gastrointestinal × Clear all
NCT00400569 2012-08-28

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
48 enrolled 9 charts
GastrointestinalSarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡